Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis.

Clin Rev Allergy Immunol · 2022 · PMC9464248 · PMID 35147864

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

identified anti-Mi-2 in 30% of patients with dermatomyositis with cancer, although the studied sample was small (2/6) and the association did not reach statistical significance [ 57 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.